Carl Casale is a distinguished leader in agriculture and venture capital, with a career that spans over four decades. His extensive experience has established him as a respected authority in these fields, where his insights have significantly influenced the transformation of global agricultural systems. As a fourth-generation farmer, he brings a unique blend of practical farming knowledge and corporate acumen, enabling him to identify and support emerging ag tech companies that contribute to sustainable food production while benefiting farmers. In his current capacity, he serves as a Senior Agricultural Partner in the venture capital sector, where his expertise drives innovation and strategic opportunities within the agricultural and food industries. He plays a pivotal role at Ospraie Ag Science, the venture arm of Ospraie Management, where he collaborates with his partners to identify, invest in, and guide promising ag tech companies. Under his leadership, Ospraie Ag Science has invested in nineteen companies that empower farmers to achieve more with fewer resources. He also holds the position of Board Chairman for two Ospraie portfolio companies, Agragene and Agrospheres, and recently joined the board of Agricola Cerro Prieto (ACP), a significant grower, shipper, and packer of asparagus, avocados, and blueberries in Peru. His career in agribusiness is marked by significant achievements, most notably during his tenure as CEO and President of CHS, Inc., the largest farmer-owned agribusiness in the United States. During his seven years at the helm, CHS experienced remarkable growth, with revenues reaching $40 billion. His strategic leadership delivered $3 billion in returns to the company’s owners and facilitated $9 billion in capital investments. Under his management, CHS’s balance sheet nearly doubled, growing from $8.7 billion in 2010 to $17.3 billion by the end of fiscal 2016. His focus on fiscal responsibility and the enhancement of management systems allowed CHS to navigate economic challenges effectively, avoiding significant workforce reductions by instead implementing strategic cost-saving measures. During this period, he also reduced working capital by $400 million, which was instrumental in funding a $2.8 billion investment in CF Nitrogen. This investment secured an 80-year production agreement and created a significant new profit stream for CHS cooperative owners. Before leading CHS, Inc., Carl served as Chief Financial Officer at Monsanto Company. His career at Monsanto began as a sales representative, and he steadily rose through the ranks to become CFO. In this critical role, he led a comprehensive restructuring of the company’s business operations, aligning its cost structure with the various phases of the agricultural cycle. This restructuring effort resulted in substantial reductions in operating expenses, saving Monsanto hundreds of millions of dollars and positioning the company for long-term success.